ADXN logo

Addex Therapeutics Ltd (ADXN) Cash From Operations

Annual CFO

-$8.90 M
+$8.33 M+48.36%

December 1, 2023

Summary

Performance

1-Year Change

+48.36%

3-Year Change

+31.49%

5-Year Change

-597.06%

15-Year Change

-309.74%

ADXN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.8%
ADXN annual cash flow from operations is higher than 61.8% of companies in Healthcare sector

High & Low

All-time High

$1.79 M
ADXN annual cash flow from operations is currently -597.06% below its historical high of $1.79 million

3-Year Low

-$17.23 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
ADXN previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
ADXN next annual earnings announcement has not yet been scheduled

OtherADXNcash flowmetrics:

Annual CFI

-$7600.00
ADXN annual cash flow from investing activities is -$7600.00

Annual CFF

$5.86 M
ADXN annual cash flow from financing activities is $5.86 million

Annual FCF

-$8.91 M
ADXN annual free cash flow is -$8.91 million

Annual CAPEX

$7600.00
ADXN annual capital expenditures is $7600.00

Quarterly CFO

-$711.80 K
+$2.25 M+75.99%

September 1, 2024

Summary

Performance

3-Month Change

+75.99%

1-Year Change

+73.15%

3-Year Change

+78.29%

5-Year Change

+85.89%

ADXN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.87%
ADXN quarterly cash flow from operations is higher than 69.87% of companies in Healthcare sector

High & Low

All-time High

$1.02 M
ADXN quarterly cash flow from operations is currently -169.79% below its historical high of $1.02 million

3-Year Low

-$5.82 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ADXN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ADXN next earnings announcement has not yet been scheduled

OtherADXNcash flowmetrics:

Quarterly CFI

$229.70 K
ADXN quarterly cash flow from investing activities is $229.70 thousand

Quarterly CFF

$4900.00
ADXN quarterly cash flow from financing activities is $4900.00

Quarterly FCF

-$713.30 K
ADXN quarterly free cash flow is -$713.30 thousand

Quarterly CAPEX

$1500.00
ADXN quarterly capital expenditures is $1500.00

TTM CFO

-$6.74 M
+$1.94 M+22.34%

September 1, 2024

Summary

Performance

3-Month Change

+22.34%

1-Year Change

+42.57%

3-Year Change

+58.09%

5-Year Change

+29.35%

ADXN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.63%
ADXN TTM cash flow from operations is higher than 64.63% of companies in Healthcare sector

High & Low

All-time High

-$2.56 M

3-Year Low

-$18.27 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ADXN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ADXN next earnings announcement has not yet been scheduled

OtherADXNcash flowmetrics:

TTM CFI

$5.39 M
ADXN TTM cash flow from investing activities is $5.39 million

TTM CFF

-$40.90 K
ADXN TTM cash flow from financing activities is -$40.90 thousand

TTM FCF

-$6.75 M
ADXN TTM free cash flow is -$6.75 million

TTM CAPEX

$2700.00
ADXN TTM capital expenditures is $2700.00

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ADXN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+48.4%+73.2%+42.6%
3 y3 years+31.5%+78.3%+58.1%
5 y5 years-597.1%+85.9%+29.4%

ADXN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+48.4%-27.9%+87.8%at high+63.1%
5 y5-yearat high+48.4%-169.8%+89.9%at high+63.1%
alltimeall time-597.1%+75.5%-169.8%+89.9%-163.7%+63.1%

Addex Therapeutics Ltd Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$711.80 K(-76.0%)
-$6.74 M(-22.3%)
Jun 2024
-
-$2.96 M(+18.1%)
-$8.68 M(-2.0%)
Mar 2024
-
-$2.51 M(+351.3%)
-$8.86 M(-0.4%)
Dec 2023
-$8.90 M(-48.4%)
-$556.30 K(-79.0%)
-$8.90 M(-24.2%)
Sep 2023
-
-$2.65 M(-15.7%)
-$11.74 M(-1.1%)
Jun 2023
-
-$3.15 M(+23.5%)
-$11.87 M(-18.4%)
Mar 2023
-
-$2.55 M(-25.0%)
-$14.54 M(-15.7%)
Dec 2022
-$17.23 M(+7.1%)
-$3.40 M(+22.3%)
-$17.23 M(+0.7%)
Sep 2022
-
-$2.78 M(-52.3%)
-$17.12 M(+0.5%)
Jun 2022
-
-$5.82 M(+10.9%)
-$17.03 M(-6.8%)
Mar 2022
-
-$5.25 M(+60.0%)
-$18.27 M(+13.6%)
Dec 2021
-$16.09 M(+23.8%)
-$3.28 M(+22.1%)
-$16.09 M(+36.5%)
Sep 2021
-
-$2.69 M(-62.0%)
-$11.79 M(-4.9%)
Jun 2021
-
-$7.06 M(+130.7%)
-$12.40 M(+5.5%)
Mar 2021
-
-$3.06 M(-400.1%)
-$11.75 M(-9.5%)
Dec 2020
-$12.99 M
$1.02 M(-130.9%)
-$12.99 M(-6.6%)
Sep 2020
-
-$3.30 M(-48.6%)
-$13.91 M(-11.2%)
Jun 2020
-
-$6.42 M(+49.2%)
-$15.66 M(+38.7%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$4.30 M(-4290.5%)
-$11.29 M(+18.3%)
Dec 2019
-$9.54 M(-633.0%)
$102.60 K(-102.0%)
-$9.54 M(-1.1%)
Sep 2019
-
-$5.04 M(+146.6%)
-$9.65 M(+109.6%)
Jun 2019
-
-$2.05 M(-20.0%)
-$4.60 M(+80.0%)
Mar 2019
-
-$2.56 M
-$2.56 M
Dec 2018
$1.79 M(-182.4%)
-
-
Dec 2017
-$2.17 M(-20.6%)
-
-
Dec 2016
-$2.74 M(+0.1%)
-
-
Dec 2015
-$2.73 M(+38.7%)
-
-
Dec 2014
-$1.97 M(-88.4%)
-
-
Dec 2013
-$17.02 M(-45.8%)
-
-
Dec 2012
-$31.41 M(+4.5%)
-
-
Dec 2011
-$30.05 M(+0.4%)
-
-
Dec 2010
-$29.94 M(-17.7%)
-
-
Dec 2009
-$36.37 M(+120.8%)
-
-
Dec 2008
-$16.47 M(-40.2%)
-
-
Dec 2007
-$27.52 M(+76.2%)
-
-
Dec 2006
-$15.62 M
-
-

FAQ

  • What is Addex Therapeutics Ltd annual cash flow from operations?
  • What is the all time high annual CFO for Addex Therapeutics Ltd?
  • What is Addex Therapeutics Ltd annual CFO year-on-year change?
  • What is Addex Therapeutics Ltd quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Addex Therapeutics Ltd?
  • What is Addex Therapeutics Ltd quarterly CFO year-on-year change?
  • What is Addex Therapeutics Ltd TTM cash flow from operations?
  • What is the all time high TTM CFO for Addex Therapeutics Ltd?
  • What is Addex Therapeutics Ltd TTM CFO year-on-year change?

What is Addex Therapeutics Ltd annual cash flow from operations?

The current annual CFO of ADXN is -$8.90 M

What is the all time high annual CFO for Addex Therapeutics Ltd?

Addex Therapeutics Ltd all-time high annual cash flow from operations is $1.79 M

What is Addex Therapeutics Ltd annual CFO year-on-year change?

Over the past year, ADXN annual cash flow from operations has changed by +$8.33 M (+48.36%)

What is Addex Therapeutics Ltd quarterly cash flow from operations?

The current quarterly CFO of ADXN is -$711.80 K

What is the all time high quarterly CFO for Addex Therapeutics Ltd?

Addex Therapeutics Ltd all-time high quarterly cash flow from operations is $1.02 M

What is Addex Therapeutics Ltd quarterly CFO year-on-year change?

Over the past year, ADXN quarterly cash flow from operations has changed by +$1.94 M (+73.15%)

What is Addex Therapeutics Ltd TTM cash flow from operations?

The current TTM CFO of ADXN is -$6.74 M

What is the all time high TTM CFO for Addex Therapeutics Ltd?

Addex Therapeutics Ltd all-time high TTM cash flow from operations is -$2.56 M

What is Addex Therapeutics Ltd TTM CFO year-on-year change?

Over the past year, ADXN TTM cash flow from operations has changed by +$5.00 M (+42.57%)